FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer (Q27851554)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q30582831)
(Q30582865)
(Q30582886)
(Q30582887)
(Q5363014)
(Q4706084)
(Q23892845)
(Q88051049)
(Q89462283)
(Q114292957)
(Q90573440)
(Q117222763)
(P304) 2085-94
(P407) (Q1860)
(P433) 5
(P478) 70
(P577) Monday, March 1, 2010
(P921) (Q128581)
(P1433) (Q326097)
(P1476) "FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer" (language: en)
(P2093) Nicholas Turner
Maria A Lopez-Garcia
Alan Mackay
(P2860) (Q24655172)
(Q24315679)
(Q24645441)
(Q24651943)
(Q24791357)
(Q27860945)
(Q28032461)
(Q28281711)
(Q28279694)
(Q28297827)
(Q28344801)
(Q28609135)
(Q29619120)
(Q37198196)
(Q39877556)
(Q39890862)
(Q39945589)
(Q33330850)
(Q38279200)
(Q39042319)
(Q35794378)
(Q40205335)
(Q40335646)
(Q36321044)
(Q36290284)
(Q34419358)
(Q36111404)
(Q38446905)
(Q36325197)
(Q42458622)
(Q42522755)
(Q42510471)
(Q42489677)
(Q52196113)
(Q42810110)
(Q41733713)
(Q45990996)
(Q54773427)
(Q44872922)
(Q45345161)
(Q42442143)
(Q53666471)
(Q57287603)
(Q79370200)
(Q57287687)
(Q72711786)
(Q74623191)
other details
aliases FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
description scientific article

External Links